Androgens target prohibitin to regulate proliferation of prostate cancer cells.

Androgens target prohibitin to regulate proliferation of prostate cancer cells.

Proteins involved in the growth response of prostate cancer cells to androgen were investigated by comparing the proteomes of LNCaP cells treated with vehicle or androgen. Whole-cell lysates were separated by two-dimensional PAGE, and HPLC-MS/MS was used to identify androgen-regulated proteins. Proh...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Gamble, S, Odontiadis, M, Waxman, J, Westbrook, J, Dunn, M, Wait, R, Lam, E, Bevan, C
Natura:	Journal article
Lingua:	English
Pubblicazione:	2004

Documenti analoghi

FUS/TLS is a novel mediator of androgen-dependent cell-cycle progression and prostate cancer growth.
di: Brooke, G, et al.
Pubblicazione: (2011)

Proteomic analysis of proteins regulated by TRPS1 transcription factor in DU145 prostate cancer cells.
di: Chang, G, et al.
Pubblicazione: (2007)

Prohibitin 2 regulates the proliferation and lineage-specific differentiation of mouse embryonic stem cells in mitochondria.
di: Megumi Kowno, et al.
Pubblicazione: (2014-01-01)

Androgen receptor signaling is required for androgen-sensitive human prostate cancer cell proliferation and survival
di: Day Wanda V, et al.
Pubblicazione: (2005-04-01)

Prohibitin: targeting peptide coupled to ovarian cancer, luteinization and TGF-β pathways
di: Nour M. El-Etreby, et al.
Pubblicazione: (2017-04-01)

Biomarker-Based Targeting of the Androgen-Androgen Receptor Axis in Advanced Prostate Cancer
di: Manish Kohli, et al.
Pubblicazione: (2012-01-01)

Androgen receptor co-regulation in prostate cancer
di: Dhirodatta Senapati, et al.
Pubblicazione: (2020-07-01)

Regulation of androgen receptor variants in prostate cancer
di: Yezi Zhu, et al.
Pubblicazione: (2020-07-01)

Targeting Prohibitins to Inhibit Melanoma Growth and Overcome Resistance to Targeted Therapies
di: Ahmad Najem, et al.
Pubblicazione: (2023-07-01)

Androgen receptor modulatory miR-1271-5p can promote hormone sensitive prostate cancer cell growth
di: Foteini Kalofonou, et al.
Pubblicazione: (2024-08-01)

Posttranslational regulation of androgen dependent and independent androgen receptor activities in prostate cancer
di: Simeng Wen, et al.
Pubblicazione: (2020-07-01)

Androgen receptor molecular biology and potential targets in prostate cancer
di: Elizabeth M. Wilson
Pubblicazione: (2010-06-01)

The Role of Prohibitin-2 in Diseases
di: Fang Liu, et al.
Pubblicazione: (2023-09-01)

Prohibitins in neurodegeneration and mitochondrial homeostasis
di: Jesus Fernandez-Abascal, et al.
Pubblicazione: (2022-11-01)

Androgen receptor and prostate cancer
di: Karen E. Livermore, et al.
Pubblicazione: (2016-06-01)

Physiological normal levels of androgen inhibit proliferation of prostate cancer cells in vitro
di: Weitao Song, et al.
Pubblicazione: (2014-12-01)

An Unusual Prohibitin Regulates Malaria Parasite Mitochondrial Membrane Potential
di: Joachim Michael Matz, et al.
Pubblicazione: (2018-04-01)

Role of the HSP90-associated cochaperone p23 in enhancing activity of the androgen receptor and significance for prostate cancer.
di: Reebye, V, et al.
Pubblicazione: (2012)

Bisphenol A promote the cell proliferation and invasion ability of prostate cancer cells via regulating the androgen receptor
di: Dong Zhang, et al.
Pubblicazione: (2024-01-01)

Androgen regulation of 5α-reductase isoenzymes in prostate cancer: implications for prostate cancer prevention.
di: Jin Li, et al.
Pubblicazione: (2011-01-01)

TCTP is an androgen-regulated gene implicated in prostate cancer.
di: Mari Kaarbø, et al.
Pubblicazione: (2013-01-01)

Prohibitin 1 interacts with p53 in the regulation of mitochondrial dynamics and chemoresistance in gynecologic cancers
di: Bao Kong, et al.
Pubblicazione: (2022-06-01)

Cellular specificity of androgen receptor, coregulators, and pioneer factors in prostate cancer
di: Damien A Leach, et al.
Pubblicazione: (2023-01-01)

Glycosylation is an androgen-regulated process essential for prostate cancer cell viability.
di: Munkley, J, et al.
Pubblicazione: (2016)

New Insights into the Androgen-Targeted Therapies and Epigenetic Therapies in Prostate Cancer
di: Abhijit M. Godbole, et al.
Pubblicazione: (2011-01-01)

Role of Androgen Receptor-Targeted Agents in Localized Prostate Cancer
di: Jure Murgić, et al.
Pubblicazione: (2022-01-01)

The evolution of prostate cancer therapy: targeting the androgen receptor (AR)
di: Jeanny B. Aragon-Ching
Pubblicazione: (2014-10-01)

Androgen Receptor-Directed Molecular Conjugates for Targeting Prostate Cancer
di: Giovanni L. Beretta, et al.
Pubblicazione: (2019-05-01)

Identification of novel androgen receptor target genes in prostate cancer
di: Gerald William L, et al.
Pubblicazione: (2007-06-01)

An androgen reduced transcript of LncRNA GAS5 promoted prostate cancer proliferation.
di: Yingyi Zhang, et al.
Pubblicazione: (2017-01-01)

Osteoblasts Promote Prostate Cancer Cell Proliferation Through Androgen Receptor Independent Mechanisms
di: Giulia Ribelli, et al.
Pubblicazione: (2021-12-01)

Functional impact of androgen‐targeted therapy on patients with castration‐resistant prostate cancer
di: Tomasz M. Beer, et al.
Pubblicazione: (2022-11-01)

The function of prohibitins in mitochondria and the clinical potentials
di: Linda Oyang, et al.
Pubblicazione: (2022-11-01)

OCIAD1 and prohibitins regulate the stability of the TIM23 protein translocase
di: Praveenraj Elancheliyan, et al.
Pubblicazione: (2024-12-01)

Correction: TCTP is an androgen-regulated gene implicated in prostate cancer.
di: Mari Kaarbø, et al.
Pubblicazione: (2015-01-01)

Androgen-regulated transcriptional control of sialyltransferases in prostate cancer cells.
di: Koji Hatano, et al.
Pubblicazione: (2012-01-01)

Expression and prognostic value of prohibitin in gastrointestinal cancers based on bioinformatics
di: LI Xiaofeng, et al.
Pubblicazione: (2024-08-01)

Glycosylation is an Androgen-Regulated Process Essential for Prostate Cancer Cell Viability
di: Jennifer Munkley, et al.
Pubblicazione: (2016-06-01)

Antioxidants Abrogate Alpha-Tocopherylquinone-Mediated Down-Regulation of the Androgen Receptor in Androgen-Responsive Prostate Cancer Cells.
di: Alexandra M Fajardo, et al.
Pubblicazione: (2016-01-01)

Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells
di: Shtutman Michael, et al.
Pubblicazione: (2010-04-01)